Immunochemistry services director joins PharmaNet

Will expand large molecule services at US firm

Chris Beaver has joined PharmaNet Development Group, a US provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, as director of immunochemistry services.

Beaver will lead the immunochemistry team within the firm’s bioanalytical laboratories and expand its large molecule services, including assay development and sample analysis for biomarker, ELISA, radioimmunoassays, immunogenicity and cell-based assays.

PharmaNet has two GLP-compliant bioanalytical laboratories located in Princeton, New Jersey and Quebec City, Canada.

You may also like

Sustainability

Guardtech supporting malaria fight in East Africa with portable 11-bay lab

Suffolk-based experts provide Cleancube Multi 11 for Oxitec’s Friendly mosquito programme in Djibouti
Ingredients

Optimising sample traceability with laser marking technology

Speed and precision in high-throughput tube identification
Ingredients

Flowchem teaching manual now available to download

Guide offers step-by-step instructions for ten reactions including Nobel Prize-winning examples
Research & Development

EazeBio and UC Santa Cruz partner to launch instrument-free diagnostic platform for global health

The pair will co-develop a lab-independent cortisol biosensor, delivering rapid, affordable and AI-guided diagnostics for stress, metabolic health and a range of global health applications
Research & Development

Biohm Technologies expands R&D footprint with new microbiome lab in Atlanta

The company has opened a state-of-the-art research lab at Portal Innovations’ Science Square campus in Atlanta, strengthening its microbiome R&D capabilities
Research & Development

Certain medicines accelerate elimination of PFAS from the body, Gothenburg study shows

Researchers at the University of Gothenburg have found that two cholesterol-lowering drugs, cholestyramine and colesevelam, can significantly speed up the removal of harmful PFAS chemicals from the body
Research & Development

Bioengineered bone marrow model successfully used in cancer research

Scientists at the University of Glasgow have successfully used the first bioengineered bone marrow model in vital leukaemia research
Subscribe now